Urolithin A & GLP-1: Supporting Muscle During Weight Loss

GLP-1 medications have changed how many people approach weight management, but rapid weight loss raises a practical question: how do you hold on to muscle while the scale moves? Urolithin A is not a weight-loss agent and it is not a treatment for anything. What it does have is a set of human trials focused on muscle function, which makes it a reasonable structure/function companion to talk through with your clinician, once the basics are in place.

Why muscle becomes the conversation on GLP-1 therapy

When body weight comes off quickly, some of what is lost is fat and some is lean tissue, including skeletal muscle. This happens with most forms of rapid weight loss, not just medication. A 2026 review of GLP-1 body-composition data in Metabolites summarized the picture: most of the weight lost is fat, but in a DXA substudy of a large tirzepatide trial roughly a quarter of the loss was lean soft tissue, and real-world measurements put lean losses at about a quarter to a third of the total (Šantić et al., Metabolites 2026). Individual results vary widely with starting muscle, age, protein intake and training, so this is a topic to review with your own prescriber using your own numbers.

Two things make muscle harder to defend on these medications. Appetite suppression often lowers protein intake at the exact moment the body needs more of it, and if activity stays low there is little signal telling the body to keep muscle. That is why the evidence-backed levers are unglamorous: adequate dietary protein, resistance training, and enough overall nutrition to support recovery. Supplements do not replace any of those. Where a mitochondrial support ingredient like urolithin A may fit is as an adjunct to that foundation, supporting the cellular machinery inside muscle rather than substituting for protein or training.

The muscle-protection basics, in practical terms

Protein you can actually eat

Many clinicians and dietitians aim for something in the range of 1.2 to 1.6 g of protein per kilogram of body weight per day during weight loss, adjusted for kidney health and individual needs. With a smaller appetite, that usually means leading each meal with the protein portion, spreading intake over three or four eating occasions, and using convenient options such as Greek yogurt, eggs, fish, tofu or a protein shake when a full meal is not realistic.

Resistance training two to three times a week

Mechanical loading is the strongest non-drug signal to keep muscle. A simple full-body routine of squats or sit-to-stands, a push, a pull, a hinge and a carry, progressed gradually, covers most of what matters. If you are new to lifting or have joint or heart concerns, a physical therapist or qualified trainer can set safe starting loads.

Track more than the scale

Strength numbers, a simple grip or sit-to-stand test, waist measurements and, where available, body-composition scans tell you whether you are losing the right kind of weight. Our blog guide on how to preserve muscle on a GLP-1 walks through a fuller weekly plan, and our explainer on GLP-1 and muscle loss covers the research on lean-mass changes in more depth.

What urolithin A actually is

Urolithin A is a gut postbiotic. When you eat ellagitannins, the polyphenols in pomegranates, walnuts and certain berries, specific gut bacteria can convert them into urolithin A. Only some people carry a microbiome that does this efficiently, which is why a standardized dose is used in research: it delivers a consistent amount regardless of your gut chemistry. Inside cells, urolithin A supports mitophagy, the housekeeping process that recycles worn-out mitochondria. Muscle is one of the most mitochondria-dense tissues in the body, which is why so much of the human research has centered there. For a fuller primer, see our urolithin A guide.

The human muscle evidence, organized by strength

Established human trials (HUMAN)

Two four-month randomized trials anchor the muscle story. Liu and colleagues studied older adults and reported improved muscle endurance, measured as contractions before fatigue, although six-minute walk distance did not differ from placebo (JAMA Network Open, 2022). Singh and colleagues studied middle-aged adults across 500 mg and 1,000 mg daily arms and reported improvements in leg muscle strength and some exercise-performance measures (Cell Reports Medicine, 2022). The first-in-human study by Andreux and colleagues established that urolithin A was safe and well tolerated up to 1,000 mg per day and produced a mitochondrial gene-expression signature (Nature Metabolism, 2019).

Newer human trials (HUMAN, smaller and shorter)

An 8-week randomized trial in 20 resistance-trained men taking 1 g a day reported better repetitions to failure and maximal isometric strength versus placebo, while changes in one-rep-max lifts were not significant (Journal of the International Society of Sports Nutrition, 2024). A 4-week trial in 42 trained distance runners found no improvement in 3,000 m time-trial performance, though perceived exertion and a post-race muscle-damage marker were lower with urolithin A (Sports Medicine, 2025). A 2025 Nature Aging randomized trial in 50 middle-aged adults reported favorable changes in immune-cell measures over four weeks (trial summary), a different tissue but consistent with the mitochondrial theme.

What this evidence does and does not say

It says urolithin A has supported several muscle-related outcomes in controlled human trials and has a reassuring safety profile in those studies. It does not say urolithin A prevents muscle loss on GLP-1 therapy, because no trial has tested that scenario. A 2024 systematic review in Ageing Research Reviews pooled five human studies of about 250 healthy people and found improvements in muscle strength and endurance but no effect on physical-function tests, and called for longer studies (Kuerec et al., 2024). That is the honest ceiling on any claim here. Our summary of the clinical studies has the full detail.

Where urolithin A could fit alongside a GLP-1 plan

Think of it as one layer on top of the essentials, not a shortcut around them. If your clinician has you on a GLP-1 medication, the muscle-protective priorities remain protein intake, resistance training and adequate nutrition. A urolithin A supplement targets the mitochondrial side of muscle cell health, the machinery behind muscle function and cellular energy. For a broader look at which supplements have the best evidence in this setting, from protein and creatine to vitamin D, see our evidence-graded guide to the best supplements to take with a GLP-1.

This is important and worth stating directly: urolithin A is not a treatment for muscle loss, sarcopenia or any medical condition, and it is not a substitute for medical care. If you are on a GLP-1 medication or losing weight rapidly, talk to your doctor before adding any supplement so it fits your specific situation and medication list.

How urolithin A is typically used

The clinically studied range is 500 to 1,000 mg per day, with 1,000 mg at the top of that range and matching the dose used in several of the trials above. The SOMA HEALTH Urolithin A Gummies deliver 1,000 mg per four-gummy daily serving: 120 gummies, a 30-day supply, raspberry flavored, sugar-free and third-party tested. Because urolithin A supports an ongoing cellular process, it is taken consistently over weeks rather than as a quick fix; our note on how long it takes to work covers realistic timelines.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.